Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

Research output: Contribution to JournalArticleAcademicpeer-review

24 Citations (Scopus)

Abstract

Background: Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ
Original languageEnglish
Pages (from-to)276-283
JournalAlzheimers & Dementia
Volume9
Issue number3
DOIs
Publication statusPublished - 2013

Cite this